NEOVACS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.134 EUR | -6.94% |
|
-62.90% | -93.30% |
| May. 29 | Neovacs: mRNA approach validated in preclinical trial | CF |
| May. 27 | Neovacs: collaboration contract with INSERM team | CF |
Summary
- Stock Market
- Equities
- ALNEV Stock
- News NEOVACS
